Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991;33(4):260-6.
doi: 10.1007/BF00230504.

The interleukin-6 gene locus seems to be a preferred target site for retrotransposon integration

Affiliations

The interleukin-6 gene locus seems to be a preferred target site for retrotransposon integration

Z H Qin et al. Immunogenetics. 1991.

Abstract

Recently, we have observed the insertion of a retrotransposon into the interleukin-6 (Il-6) locus of a mouse somatic cell line. Here we report the characterization of Il-6 genomic regions from both mouse and rat. Restriction site analysis, DNA sequence analysis, and computer-assisted search revealed eight retrotransposon-like elements distributed over a 25 kilobase (kb) mouse Il-6 region. In the rat, five different retrotransposons have been identified within a 17 kb Il-6 region. The retrotransposons belong to the LINE-, Alu I or Alu II families, or to a rat specific class of retrotransposons. Some of the retrotransposons exhibit characteristic features such as target site duplication and a poly A-tract. Remarkably, several retrotransposons map to different chromosomal locations in the mouse and rat. A genealogical tree of mouse, rat, and human Il-6 loci demonstrates a series of retrotranspositions that recently occurred in evolution. These results suggest that the Il-6 locus serves as a preferred target site for retrotransposon integration during evolution.

PubMed Disclaimer

References

    1. Nature. 1988 Mar 10;332(6160):164-6 - PubMed
    1. J Immunol. 1988 Dec 1;141(11):3875-81 - PubMed
    1. Cell. 1982 Mar;28(3):433-4 - PubMed
    1. EMBO J. 1987 Oct;6(10):2939-45 - PubMed
    1. Mol Immunol. 1989 Nov;26(11):1021-6 - PubMed

Publication types